clofibric acid has been researched along with Jaundice, Neonatal in 2 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Jaundice, Neonatal: Yellow discoloration of the SKIN; MUCOUS MEMBRANE; and SCLERA in the NEWBORN. It is a sign of NEONATAL HYPERBILIRUBINEMIA. Most cases are transient self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) occurring in the first week of life, but some can be a sign of pathological disorders, particularly LIVER DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clofibrate (CFB) has been proposed to increase elimination of bilirubin in neonates with hyperbilirubinemia." | 1.29 | [Pharmacokinetics of clofibrate in jaundiced newborn infants at term]. ( Bourget, P; Broise, I; Gabilan, JC; Quinquis-Desmaris, V, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barré, J | 1 |
| Houin, G | 1 |
| Shastri, RA | 1 |
| Benattar, C | 1 |
| Lindenbaum, A | 1 |
| Tillement, JP | 1 |
| Bourget, P | 1 |
| Broise, I | 1 |
| Quinquis-Desmaris, V | 1 |
| Gabilan, JC | 1 |
2 other studies available for clofibric acid and Jaundice, Neonatal
| Article | Year |
|---|---|
Effect of hyperbilirubinaemia on the plasma protein binding of chlorophenoxyisobutyric acid in neonates.
Topics: Bilirubin; Blood Proteins; Clofibrate; Clofibric Acid; Humans; Infant, Newborn; Jaundice, Neonatal; | 1984 |
[Pharmacokinetics of clofibrate in jaundiced newborn infants at term].
Topics: Anticholesteremic Agents; Clofibrate; Clofibric Acid; Drug Administration Schedule; Female; Humans; | 1995 |